Technical Analysis for VRNA - Verona Pharma plc

Grade Last Price % Change Price Change
grade D 6.57 -1.35% -0.09
VRNA closed down 1.35 percent on Monday, September 21, 2020, on 2 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical VRNA trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -1.35%
NR7 Range Contraction -1.35%
Doji - Bullish? Reversal -1.35%
Bollinger Band Squeeze Range Contraction -3.38%
BB Squeeze Started Range Contraction -3.38%
Older End-of-Day Gignals for VRNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 23 hours ago
Lower Bollinger Band Support about 24 hours ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company’s lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Respiratory Therapy Asthma Cystic Fibrosis Chronic Obstructive Pulmonary Disease Respiratory Diseases Lactams Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease

Is VRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.71
52 Week Low 2.01
Average Volume 2,174,612
200-Day Moving Average 5.56
50-Day Moving Average 7.27
20-Day Moving Average 7.03
10-Day Moving Average 6.90
Average True Range 0.53
ADX 17.63
+DI 16.10
-DI 21.91
Chandelier Exit (Long, 3 ATRs ) 6.72
Chandelier Exit (Short, 3 ATRs ) 7.60
Upper Bollinger Band 7.67
Lower Bollinger Band 6.40
Percent B (%b) 0.14
BandWidth 18.01
MACD Line -0.15
MACD Signal Line -0.09
MACD Histogram -0.0589
Fundamentals Value
Market Cap 72.69 Million
Num Shares 11.1 Million
EPS -1.51
Price-to-Earnings (P/E) Ratio -4.35
Price-to-Sales 0.00
Price-to-Book 1.25
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.31
Resistance 3 (R3) 7.28 7.01 7.18
Resistance 2 (R2) 7.01 6.82 7.02 7.14
Resistance 1 (R1) 6.79 6.71 6.66 6.82 7.10
Pivot Point 6.52 6.52 6.45 6.53 6.52
Support 1 (S1) 6.30 6.33 6.17 6.33 6.04
Support 2 (S2) 6.03 6.22 6.04 6.00
Support 3 (S3) 5.81 6.03 5.96
Support 4 (S4) 5.84